Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease

Published:2018-03-19 Issue:3 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Walters Julia AE¹,Tan Daniel J²,White Clinton J²,Wood-Baker Richard²

Affiliation:

1. La Trobe University; 55 Commercial Rd Alfred Health Clinical School Melbourne Victoria Australia 3004

2. University of Tasmania; School of Medicine; Hobart Tasmania Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference93 articles.

1. The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract];Chen;European Respiratory Journal,2005

2. [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese];Chen;Chinese Journal of Tuberculosis and Respiratory Diseases [Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih],2008

3. Gomaa M Faramawy M Ibrahim H Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract] European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin 2008 [P3601]

4. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial;Leuppi;JAMA,2013

5. Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial;Schuetz;Eur J Endocrinol,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of pharmacotherapy efficacy for the treatment of exacerbations of chronic obstructive pulmonary disease associated with viral infection;Clinical Medicine (Russian Journal);2024-05-09

2. Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysis;Respiratory Investigation;2024-05

3. Influencing factors of good quality of life among chronic obstructive pulmonary disease patients living in Zhejiang Province, China;Scientific Reports;2024-04-15

4. Individualised treatment of COPD exacerbations using biomarkers;Ugeskrift for Læger;2024-04-01

5. Progression of Corticosteroid Use in Patients with Chronic Obstructive Pulmonary Disease during the Pandemic of Novel Coronavirus Infection;Advances in Clinical Medicine;2024